| Jan 2, 2020 |
2020 FC 1 |
Seedlings Life Sciences v Pfizer
We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...
|
Patents
|
|
| Apr 10, 2018 |
Federal Court File Nos. T-598-17 through T-605-17 |
AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA. The c...
|
Patents
|
|
| Apr 9, 2018 |
Federal Court File No. T-1355-17 |
Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...
|
Patents
|
|
| Feb 8, 2018 |
2018 FCA 33 |
Teva Canada Limited v. Janssen Inc.
We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...
|
Patents
|
|
| Nov 18, 2016 |
2016 ONSC 7151 |
Actavis Pharma Company v Alcon Canada Inc. et al.
We obtained an order dismissing Actavis’ claims for monetary relief under the UK and Ontario Statutes of Monopolies, in an action for damage...
|
Patents
|
|
| May 31, 2016 |
2016 FC 593 |
Janssen Inc. v. Teva Canada Limited
We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....
|
Patents
|
|